PB2079: INTERIM REPORT OF BENDAMUSTINE PLUS RITUXIMAB AS FIRST-LINE INDUCTION THERAPY WITH OR WITHOUT LENALIDOMIDE MAINTENANCE THERAPY IN CHINESE PATIENTS WITH INHL OR EMCL: A MULTI-CENTER PROSPECTIVE TRIAL

Bibliographic Details
Main Authors:	H. Wang, Q. He, R. Zhao, L. Xie, J. Ma, C. Liu, K. Lu, H. Wei, D. Liu, L. Xing, X. Deng, Z. Sun, X. Chu, N. Gao, Y. Zhong, Y. Sun, H. Zhang, W. Xu, Z. Li
Format:	Article
Language:	English
Published:	Wiley 2022-06-01
Series:	HemaSphere
Online Access:	http://journals.lww.com/10.1097/01.HS9.0000851148.10454.66

Internet